Filing Details

Accession Number:
0001246360-11-002529
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-05-17 18:40:15
Reporting Period:
2011-05-13
Filing Date:
2011-05-17
Accepted Time:
2011-05-17 18:40:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
859368 Medicis Pharmaceutical Corp MRX Pharmaceutical Preparations (2834) 521574808
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1430423 D Richard Peterson 7720 N. Dobson Rd.
Scottsdale AZ 85256
Evp, Cfo & Corp Treasurer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-05-13 3,710 $26.95 158,923 No 4 M Direct
Common Stock Acquisiton 2011-05-13 30,290 $26.95 189,213 No 4 M Direct
Common Stock Acquisiton 2011-05-13 36,000 $29.20 225,213 No 4 M Direct
Common Stock Acquisiton 2011-05-13 15,000 $32.41 240,213 No 4 M Direct
Common Stock Disposition 2011-05-13 42,500 $36.79 197,713 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option Disposition 2011-05-13 3,710 $0.00 3,710 $26.95
Common Stock Employee Stock Option Disposition 2011-05-13 30,290 $0.00 30,290 $26.95
Common Stock Employee Stock Option Disposition 2011-05-13 36,000 $0.00 36,000 $29.20
Common Stock Employee Stock Option Disposition 2011-05-13 15,000 $0.00 15,000 $32.41
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2002-07-17 2011-07-17 No 4 M Direct
0 2002-07-17 2011-07-17 No 4 M Direct
0 2004-07-31 2013-07-31 No 4 M Direct
0 2006-07-21 2015-07-21 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 197,713 Direct
Footnotes
  1. Amount of Securities Beneficially Owned in Column 5 reflects a transfer to the reporting officer's former spouse of 42,500 shares on May 13, 2011, upon the exercise of stock options, pursuant to a divorce settlement decree.
  2. The exercise of 50% of the stock options was at the direction of the reporting officer's former spouse pursuant to a divorce settlement decree.
  3. Exercised stock options were scheduled to expire on July 17, 2011.
  4. The exercise of 50% of the stock options was at the direction of the reporting officer's former spouse pursuant to a divorce settlement decree.
  5. Exercised stock options were scheduled to expire on July 17, 2011.
  6. The exercise of 50% of the stock options was at the direction of the reporting officer's former spouse pursuant to a divorce settlement decree.
  7. The exercise of 50% of the stock options was at the direction of the reporting officer's former spouse pursuant to a divorce settlement decree.
  8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.50 to $37.31, inclusive.